AN2 Therapeutics, Inc. (ANTX): 10-Q filed May 11, 2026

Form type
10-Q
Filing date
May 11, 2026
Accession number
0001193125-26-216755
Filer
AN2 Therapeutics, Inc. (CIK 1880438)